Anavex Life Sciences: Negative CHMP Decision Does Not Bode Well For Future Approval For Alzheimer's

Anavex Life Sciences' Phase 2B/3 trial failed to achieve statistical significance on both primary endpoints. Read why I ...
EuropaWire

Nokia powers major upgrade of KPN’s national core network as FabriQ becomes the foundation for the Netherlands’ digital future

Nokia has been selected by KPN to rebuild the Netherlands’ core digital infrastructure through an 800G-capable IP and optical network that forms the heart of KPN’s FabriQ architecture. The upgrade ...
EuropaWire

Ericsson deepens industry ecosystem for network APIs with minority investment and strategic partnership with LotusFlare

Ericsson has formed a strategic partnership with LotusFlare and taken a minority stake in the company to support global CSPs in commercializing network capabilities through APIs. LotusFlare’s DNO ...